Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 13, 2019Turkish Journal of HematologyOpen Access

Extended Half-Life (EHL) Coagulation Factors: A New Era in the Management of Haemophilia Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMuhlis Cem ArIstanbul University-CerrahpaşaCBCan BalkanEge UniversityKKKaan KavaklıIzmir University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ar et al. (2019) studied this question.

synapsesocial.com/papers/6a204596e63646fdcd45f3bbhttps://doi.org/10.4274/tjh.galenos.2019.2018.0393
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products2016 · 60 citations
  2. 2Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study2014 · 7 citations
  3. 3Defining extended half‐life rFVIII —A critical review of the evidence2018 · 92 citations
  4. 4New therapies for hemophilia2016 · 44 citations
  5. 5Novel therapies and current clinical progress in hemophilia A2017 · 63 citations